Impact of a Clinical Pharmacist Stress Ulcer Prophylaxis Management Program on Inappropriate Use in Hospitalized Patients

被引:68
|
作者
Buckley, Mitchell S. [1 ]
Park, Andrew S. [1 ]
Anderson, Clint S. [1 ]
Barletta, Jeffrey F. [2 ]
Bikin, Dale S. [1 ]
Gerkin, Richard D. [1 ]
O'Malley, Cheryl W. [1 ]
Wicks, Laura M. [1 ]
Garcia-Orr, Roxanne [1 ]
Kane-Gill, Sandra L. [3 ]
机构
[1] Banner Univ, Med Ctr Phoenix, Phoenix, AZ 85006 USA
[2] Midwestern Univ, Glendale, AZ USA
[3] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA
来源
AMERICAN JOURNAL OF MEDICINE | 2015年 / 128卷 / 08期
关键词
Acid suppression therapy; Clinical pharmacy; Histamine-2 receptor antagonist; Proton pump inhibitor; Stress ulcer prophylaxis; PROTON-PUMP INHIBITORS; HISTAMINE-2 RECEPTOR ANTAGONISTS; INDUCED THROMBOCYTOPENIA; COST-EFFECTIVENESS; ECONOMIC-IMPACT; RISK-FACTORS; SUCRALFATE; OVERUTILIZATION; THERAPY; DISEASE;
D O I
10.1016/j.amjmed.2015.02.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: Appropriate utilization of stress ulcer prophylaxis should be limited to high-risk, intensive care unit (ICU) patients. However, inappropriate stress ulcer prophylaxis use among all hospitalized patients remains a concern. The purpose of this study was to evaluate the clinical and economic impact of a novel pharmacist-managed stress ulcer prophylaxis program in ICU and general ward patients. METHODS: This retrospective, pre- and poststudy design was conducted in adult ICU and general ward patients at a large academic medical center between January 1, 2011 and January 31, 2012 to compare the rates of inappropriate stress ulcer prophylaxis before and after the implementation of a pharmacist-led stress ulcer prophylaxis management program. RESULTS: A total of 1134 unique patients consisting of 16,415 patient days were evaluated. The relative reduction in the rate of inappropriate stress ulcer prophylaxis days after program implementation in ICU and general ward patients was 58.3% and 83.5%, respectively (P < .001). The rates of ICU patients inappropriately continued on stress ulcer prophylaxis upon hospital discharge in the pre- and post-implementation groups were 29.9% and 3.6%, respectively (P < .001), whereas general ward patients significantly decreased from 36.2% to 5.4% in the pre- and postimplementation groups, respectively (P < .001). Total inpatient costs associated with all stress ulcer prophylaxis administered was $20,052.70 in the pre- and $3280.49 in the postimplementation group (P < .001), resulting in an estimated cost savings of > $200,000 annually. No differences in clinical outcomes were observed. CONCLUSIONS: The implementation of a pharmacist-managed stress ulcer prophylaxis program was associated with a decrease in inappropriate acid suppression rates during hospitalization and upon discharge, as well as significant cost savings. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:905 / 913
页数:9
相关论文
共 50 条
  • [1] Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients
    Heidelbaugh, Joel J.
    Inadomi, John M.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (10): : 2200 - 2205
  • [2] Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-intensive care unit hospitalized patients
    Heidelbaugh, JJ
    Inadomi, JM
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S274 - S274
  • [3] Impact of a multidisciplinary quality improvement initiative to reduce inappropriate usage of stress ulcer prophylaxis in hospitalized patients
    Choi, Yeo Jin
    Sim, Joohyun
    Jung, Yun Tae
    Shin, Sooyoung
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (05) : 903 - 912
  • [4] THE ECONOMIC IMPACT OF A STRESS ULCER PROPHYLAXIS PHARMACY PROGRAM TARGETING INAPPROPRIATE THERAPY
    Buckley, Mitchell
    Park, Andrew
    Anderson, Clint
    Barletta, Jeffrey
    Bikin, Dale
    Gerkin, Richard
    O'Malley, Cheryl
    Kane-Gill, Sandra
    [J]. CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [5] Stress Ulcer Prophylaxis in Hospitalized Patients
    Anderson, Mary E.
    [J]. HOSPITAL MEDICINE CLINICS, 2013, 2 (01) : E32 - E44
  • [6] APPROPRIATENESS OF STRESS ULCER PROPHYLAXIS IN HOSPITALIZED PATIENTS
    Chen, Patrick
    Reddy, Nikhil
    Loesch, Erin
    Agrawal, Sangeeta
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S122 - S123
  • [7] PREVALENCE OF INAPPROPRIATE STRESS ULCER PROPHYLAXIS IN TRAUMA PATIENTS
    Bowling, William
    Buterakos, Roxanne
    [J]. CRITICAL CARE MEDICINE, 2009, 37 (12) : A75 - A75
  • [8] Medication use evaluation on the inappropriate use of stress ulcer prophylaxis in general medicine and surgical patients
    Boulton, Cindy
    Miller, Susan
    [J]. PHARMACOTHERAPY, 2015, 35 (11): : E288 - E289
  • [9] Inappropriate use of stress ulcer prophylaxis in the intensive care setting: Impact on patient care and cost
    Manne, S
    Bentley, ML
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (12) : A184 - A184
  • [10] Pharmacist-Led Intervention on the Inappropriate Use of Stress Ulcer Prophylaxis Pharmacotherapy in Intensive Care Units: A Systematic review
    Xu, Peipei
    Yi, Qiusha
    Wang, Cuitong
    Zeng, Linan
    Olsen, Keith M.
    Zhao, Rongsheng
    Jiang, Mingyan
    Xu, Ting
    Zhang, Lingli
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12